Report Detail

Request for Sample of this report

Pharma & Healthcare Global Pets Anti-infective Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4663060
    • |
  • 19 January, 2026
    • |
  • Global
    • |
  • 122 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pets Anti-infective Drugs market size was valued at US$ 2504 million in 2025 and is forecast to a readjusted size of US$ 7244 million by 2032 with a CAGR of 16.6% during review period.
Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
The pet anti-infective drug market is a growing area. With the expansion of the global pet market and the improvement of pet health awareness, this market has shown great development potential.
The pet anti-infective drug market is dominated by many well-known companies, such as Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products and Ceva Santé Animale, which have deep technical accumulation and market experience in veterinary drug research and development, production and market operation.
The market concentration is high, and a few companies occupy a large market share, but with the entry of new companies and the intensification of market competition, the market pattern may change.
Pet anti-infective drugs mainly include antibiotics, antibacterial drugs and other types, which are used to prevent and treat various bacterial infections of pets. These drugs play an important role in improving the quality of life of pets and prolonging their lifespan.
With the advancement of science and technology and the increase in R&D investment, new products and new therapies will continue to emerge in the pet anti-infective drug market. These innovative products will have better efficacy, lower side effects and higher safety, meeting the diverse needs of pet owners.
With the development of precision medicine, the pet anti-infective drug market will pay more attention to personalized treatment in the future. Providing customized anti-infection treatment plans for pets of different types, ages, and health conditions will become an important direction for market development.
This report is a detailed and comprehensive analysis for global Pets Anti-infective Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Administration Method and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pets Anti-infective Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pets Anti-infective Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pets Anti-infective Drugs market size and forecasts, by Administration Method and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pets Anti-infective Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pets Anti-infective Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pets Anti-infective Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santé Animale, Vetoquinol, Nanjing Jindun Animal, Wuhan Chopperlvya, Bimeda Animal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pets Anti-infective Drugs market is split by Administration Method and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Administration Method, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Administration Method
External Use
Internal Use
Injection
Market segment by Application
Dog
Cat
Others
Major players covered
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Hanvet Pet Health
Wuhan Hvsen Biotechnology
Zhejiang Hisun Animal Healthcare Products
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pets Anti-infective Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pets Anti-infective Drugs, with price, sales quantity, revenue, and global market share of Pets Anti-infective Drugs from 2021 to 2026.
Chapter 3, the Pets Anti-infective Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pets Anti-infective Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Administration Method and by Application, with sales market share and growth rate by Administration Method, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pets Anti-infective Drugs market forecast, by regions, by Administration Method, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pets Anti-infective Drugs.
Chapter 14 and 15, to describe Pets Anti-infective Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Administration Method
    • 1.3.1 Overview: Global Pets Anti-infective Drugs Consumption Value by Administration Method: 2021 Versus 2025 Versus 2032
    • 1.3.2 External Use
    • 1.3.3 Internal Use
    • 1.3.4 Injection
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pets Anti-infective Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Dog
    • 1.4.3 Cat
    • 1.4.4 Others
  • 1.5 Global Pets Anti-infective Drugs Market Size & Forecast
    • 1.5.1 Global Pets Anti-infective Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pets Anti-infective Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Pets Anti-infective Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Zoetis
    • 2.1.1 Zoetis Details
    • 2.1.2 Zoetis Major Business
    • 2.1.3 Zoetis Pets Anti-infective Drugs Product and Services
    • 2.1.4 Zoetis Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Zoetis Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Pets Anti-infective Drugs Product and Services
    • 2.2.4 Merck Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Elanco
    • 2.3.1 Elanco Details
    • 2.3.2 Elanco Major Business
    • 2.3.3 Elanco Pets Anti-infective Drugs Product and Services
    • 2.3.4 Elanco Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Elanco Recent Developments/Updates
  • 2.4 Virbac
    • 2.4.1 Virbac Details
    • 2.4.2 Virbac Major Business
    • 2.4.3 Virbac Pets Anti-infective Drugs Product and Services
    • 2.4.4 Virbac Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Virbac Recent Developments/Updates
  • 2.5 Dechra Veterinary Products
    • 2.5.1 Dechra Veterinary Products Details
    • 2.5.2 Dechra Veterinary Products Major Business
    • 2.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Product and Services
    • 2.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Dechra Veterinary Products Recent Developments/Updates
  • 2.6 Ceva Santé Animale
    • 2.6.1 Ceva Santé Animale Details
    • 2.6.2 Ceva Santé Animale Major Business
    • 2.6.3 Ceva Santé Animale Pets Anti-infective Drugs Product and Services
    • 2.6.4 Ceva Santé Animale Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ceva Santé Animale Recent Developments/Updates
  • 2.7 Vetoquinol
    • 2.7.1 Vetoquinol Details
    • 2.7.2 Vetoquinol Major Business
    • 2.7.3 Vetoquinol Pets Anti-infective Drugs Product and Services
    • 2.7.4 Vetoquinol Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Vetoquinol Recent Developments/Updates
  • 2.8 Nanjing Jindun Animal
    • 2.8.1 Nanjing Jindun Animal Details
    • 2.8.2 Nanjing Jindun Animal Major Business
    • 2.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Product and Services
    • 2.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Nanjing Jindun Animal Recent Developments/Updates
  • 2.9 Wuhan Chopperlvya
    • 2.9.1 Wuhan Chopperlvya Details
    • 2.9.2 Wuhan Chopperlvya Major Business
    • 2.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Product and Services
    • 2.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Wuhan Chopperlvya Recent Developments/Updates
  • 2.10 Bimeda Animal Health
    • 2.10.1 Bimeda Animal Health Details
    • 2.10.2 Bimeda Animal Health Major Business
    • 2.10.3 Bimeda Animal Health Pets Anti-infective Drugs Product and Services
    • 2.10.4 Bimeda Animal Health Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bimeda Animal Health Recent Developments/Updates
  • 2.11 Ouro Fino Saude
    • 2.11.1 Ouro Fino Saude Details
    • 2.11.2 Ouro Fino Saude Major Business
    • 2.11.3 Ouro Fino Saude Pets Anti-infective Drugs Product and Services
    • 2.11.4 Ouro Fino Saude Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Ouro Fino Saude Recent Developments/Updates
  • 2.12 Norbrook
    • 2.12.1 Norbrook Details
    • 2.12.2 Norbrook Major Business
    • 2.12.3 Norbrook Pets Anti-infective Drugs Product and Services
    • 2.12.4 Norbrook Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Norbrook Recent Developments/Updates
  • 2.13 Hanvet Pet Health
    • 2.13.1 Hanvet Pet Health Details
    • 2.13.2 Hanvet Pet Health Major Business
    • 2.13.3 Hanvet Pet Health Pets Anti-infective Drugs Product and Services
    • 2.13.4 Hanvet Pet Health Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hanvet Pet Health Recent Developments/Updates
  • 2.14 Wuhan Hvsen Biotechnology
    • 2.14.1 Wuhan Hvsen Biotechnology Details
    • 2.14.2 Wuhan Hvsen Biotechnology Major Business
    • 2.14.3 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product and Services
    • 2.14.4 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Wuhan Hvsen Biotechnology Recent Developments/Updates
  • 2.15 Zhejiang Hisun Animal Healthcare Products
    • 2.15.1 Zhejiang Hisun Animal Healthcare Products Details
    • 2.15.2 Zhejiang Hisun Animal Healthcare Products Major Business
    • 2.15.3 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product and Services
    • 2.15.4 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Zhejiang Hisun Animal Healthcare Products Recent Developments/Updates

3 Competitive Environment: Pets Anti-infective Drugs by Manufacturer

  • 3.1 Global Pets Anti-infective Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pets Anti-infective Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pets Anti-infective Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pets Anti-infective Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pets Anti-infective Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pets Anti-infective Drugs Manufacturer Market Share in 2025
  • 3.5 Pets Anti-infective Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Pets Anti-infective Drugs Market: Region Footprint
    • 3.5.2 Pets Anti-infective Drugs Market: Company Product Type Footprint
    • 3.5.3 Pets Anti-infective Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pets Anti-infective Drugs Market Size by Region
    • 4.1.1 Global Pets Anti-infective Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pets Anti-infective Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pets Anti-infective Drugs Average Price by Region (2021-2032)
  • 4.2 North America Pets Anti-infective Drugs Consumption Value (2021-2032)
  • 4.3 Europe Pets Anti-infective Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pets Anti-infective Drugs Consumption Value (2021-2032)
  • 4.5 South America Pets Anti-infective Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pets Anti-infective Drugs Consumption Value (2021-2032)

5 Market Segment by Administration Method

  • 5.1 Global Pets Anti-infective Drugs Sales Quantity by Administration Method (2021-2032)
  • 5.2 Global Pets Anti-infective Drugs Consumption Value by Administration Method (2021-2032)
  • 5.3 Global Pets Anti-infective Drugs Average Price by Administration Method (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pets Anti-infective Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Pets Anti-infective Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Pets Anti-infective Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pets Anti-infective Drugs Sales Quantity by Administration Method (2021-2032)
  • 7.2 North America Pets Anti-infective Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Pets Anti-infective Drugs Market Size by Country
    • 7.3.1 North America Pets Anti-infective Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pets Anti-infective Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pets Anti-infective Drugs Sales Quantity by Administration Method (2021-2032)
  • 8.2 Europe Pets Anti-infective Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pets Anti-infective Drugs Market Size by Country
    • 8.3.1 Europe Pets Anti-infective Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pets Anti-infective Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Administration Method (2021-2032)
  • 9.2 Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pets Anti-infective Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Pets Anti-infective Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pets Anti-infective Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pets Anti-infective Drugs Sales Quantity by Administration Method (2021-2032)
  • 10.2 South America Pets Anti-infective Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Pets Anti-infective Drugs Market Size by Country
    • 10.3.1 South America Pets Anti-infective Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pets Anti-infective Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Administration Method (2021-2032)
  • 11.2 Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pets Anti-infective Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Pets Anti-infective Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pets Anti-infective Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pets Anti-infective Drugs Market Drivers
  • 12.2 Pets Anti-infective Drugs Market Restraints
  • 12.3 Pets Anti-infective Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pets Anti-infective Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pets Anti-infective Drugs
  • 13.3 Pets Anti-infective Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pets Anti-infective Drugs Typical Distributors
  • 14.3 Pets Anti-infective Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pets Anti-infective Drugs. Industry analysis & Market Report on Pets Anti-infective Drugs is a syndicated market report, published as Global Pets Anti-infective Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pets Anti-infective Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo